NEJM Roundtable: CABG vs. Stenting: Clinical Implications of the SYNTAX Trial, Part I

In the international SYNTAX trial, 1800 patients with three-vessel or left main coronary artery disease were randomly assigned to either revascularization with coronary-artery bypass grafting (CABG) or percutaneous coronary intervention involving drug-eluting stents. The need for repeat revascularization was significantly lower with CABG, but the risk of stroke was significantly higher — a tradeoff that must be considered in making clinical decisions regarding patients with advanced coronary disease. In a roundtable discussion moderated by Dr. Thomas Lee, cardiologists David Hillis and Elizabeth Nabel debate the implications of these findings for clinical practice.

Category:

Science & Technology

Tags:

• Thomas Lee
• David Hillis
• Elizabeth Nabel
• SYNTAX trial
• cardiovascular diseases
• angioplasty
• coronary artery bypass
• drug-eluting stents
• coronary artery disease

[Fernandohayabusa]

what about he mortality associated with the surgery itself? Isn't it higher with CABG over the PCI? I was wondering.